Exploring how physical activity affects fatigue in cancer survivors
Official title: Relationships Between Physical Activity and Different Measures of Fatigue in Cancer Survivors
Run by University of Colorado, Denver · NCT05073848 · Data updated 2026-11-12
This study is testing how daily exercise can help reduce fatigue in cancer survivors who are participating in a three-month exercise program.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | October 20, 2021 |
| Main results expected | June 1, 2027 |
| Study ends | June 1, 2028 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT05073848 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are active participants in the BfitBwell Cancer Exercise Program and are currently receiving or have recently completed cancer therapy.
✕Probably not a fit
Patients who are not currently undergoing cancer therapy or have not completed therapy within the last six months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This investigation examines the relationship between daily physical activity and various measures of fatigue in cancer survivors enrolled in a cancer exercise program. Participants will engage in a three-month exercise program, during which they will respond to daily fatigue assessments via a smartphone app and wear a physical activity monitor for ten days at the beginning and end of the program. The findings aim to enhance exercise prescriptions and timing to effectively reduce fatigue in this population.
Why it matters
Potential benefit: If successful, this study could lead to improved exercise guidelines that help cancer survivors manage fatigue more effectively.
How similar studies have gone: While this approach is not widely tested, similar studies have shown promising results in understanding the impact of physical activity on fatigue in cancer survivors.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be an active participant in the BfitBwell Cancer Exercise Program * Criteria for this program include: * Adult (\>= 18 years old) * Being a patient seen at the University of Colorado Cancer Center * Currently receiving cancer therapy or be within 6 months of completing cancer therapy * Have a signed physician clearance form to participate in an exercise program * Have a smartphone (necessary for the EMA assessments) * A score of 48 or less on the FACIT-Fatigue (completed during the initial BfitBwell Program assessment) * The minimally important difference of the FACIT-Fatigue is 3 points, suggesting that a score of at most 48 indicates the presence of CRF and allows for meaningful change in both directions. Exclusion Criteria: * None
Where it's running
-
University of Colorado Cancer Center
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Ryan Marker, PhD, PT — University of Colorado, Denver
- Study coordinator: Jared Scorsone
- Email: JARED.SCORSONE@CUANSCHUTZ.EDU
- Phone: 303-724-1264
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term follow-up of fertility preservation in women after cancer remission
This project will see how fertility preservation options work long-term for women in remission from cancer or hematological disease, including how often preserved material is used and the psychological effects.
-
30-day outcomes for cancer patients treated in specialist versus non-specialist emergency departments
This study will see if adults with active cancer or cancer remission within the past year who go to a specialist cancer emergency department have different 30-day death and complication rates compared with those who go to non-specialist emergency departments.
-
Preventing GvHD in patients with blood cancers undergoing stem cell transplants
This study is testing a new treatment called TRX-103 to see if it can help prevent graft-versus-host disease in people with blood cancers who are getting stem cell transplants from mismatched donors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.